Nonmelanoma Skin Cancer
From the Journals
HPV vaccine: New therapeutic option for SCC?
In a case report of an immunocompetent woman with multiple inoperable cutaneous basaloid SCCs, all tumors resolved within 11 months after the...
For Residents
Intravascular Involvement of Cutaneous Squamous Cell Carcinoma
We present a case of a 72-year-old man who was found to have intravascular invasion during Mohs micrographic surgery (MMS) of cutaneous squamous...
From the Journals
Cutavirus shows no association with primary cutaneous lymphoma
Biopsy analysis argues against pathogenic role for cutavirus in B- and T-cell disease.
Peer to Peer
Extramammary Paget Disease: Making the Correct Diagnosis
Conference Coverage
Registry data provide evidence that Mohs surgery remains underutilized
CHICAGO – Surprisingly, the use of Mohs dropped for those with melanoma in situ after the Affordable Care Act was implemented.
Conference Coverage
Study pinpoints skin cancer risk factors after hematopoietic cell transplant
CHICAGO – Fitzpatrick skin types I and II boost risk 7- to 9-fold.
Peer to Peer
New Guidelines for Nonmelanoma Skin Cancer: What You Need to Know
Conference Coverage
Nevus count tied to BCC risk
No link between nevus count and squamous cell carcinoma risk.
Case Reports
Unusual Presentation of Ectopic Extramammary Paget Disease
Extramammary Paget disease (EMPD) is a malignant tumor typically found in apocrine-rich areas of the skin, particularly in the anogenital region....
From the Journals
Checkpoint inhibitor shows promise in advanced squamous-cell carcinoma
The PD-1 inhibitor cemiplimab has shown a response rate in about half of patients with advanced or metastatic cutaneous squamous-cell carcinoma....
From the Journals
Psoriasis therapy with biologics not linked to increased cancer risk
The international case-control study using registry data looked at risk in real-world clinical practice.